Selected engagements

UX strategy and
competitive analysis
in regulated environments.

UX strategy, competitive intelligence, and audit — agency-side, across FDA, MLR, and HIPAA-regulated brands.


UX Strategy · IA · Experience Design
Eli Lilly Clinical Trials — Patient Experience Strategy & IA

Led UX strategy and information architecture for a patient-facing clinical trial participation platform. Reframed the experience as a guided decision journey — behavioral arc mapping, progressive disclosure design, and regulatory-compliant IA from discovery through enrollment.

MLR-ready experience architecture · 3-stage progressive disclosure
Eli Lilly Clinical Trials
UX Audit · Experience Design · CRM
Abbott FreeStyle Libre — UX Audit & Lifecycle Experience Design

Identified UX friction causing 20% patient drop-off across HCP onboarding and device activation. Delivered lifecycle service blueprint, communication architecture, and MLR-compliant experience design recommendations across an 88-day engagement program.

20% drop-off reduction via UX audit & experience redesign
Abbott FreeStyle Libre
Experience Design · CI · UX Architecture
Eli Lilly Verzenio — Experience Architecture & Competitive Intelligence

Designed oncology experience architecture serving early and metastatic breast cancer patients from one platform. Two distinct UX sequencing models (EBC: Emotion→Evidence→Action; MBC: Evidence→Context→Support) alongside competitive landscape benchmarking.

Dual-audience UX architecture · MLR-approved DTC platform
Eli Lilly Verzenio
Experience Design · Global UX · CI
Eli Lilly Global Obesity — Digital Experience Design & Strategy

Designed a global UX framework — IA, content hierarchy, and page-level experience design — that scales across markets with differing regulatory environments and cultural contexts. AI-augmented competitive intelligence accelerated cross-market pattern synthesis.

Global UX design framework · AI-augmented CI
Eli Lilly Global Obesity

Full case study detail — UX strategy rationale, experience design deliverables, methodologies, and engagement scope — is available for each of the four engagements above. Select work available on request due to NDA constraints. Contact me to discuss.


Luria Advisory

Fractional UX strategy, competitive intelligence, and digital audit practice. Available for project-based engagements.

luriaadvisory.com →
UX StrategyIAExperience DesignClinical TrialsRegulatory Compliance

Eli Lilly Clinical Trials — Patient Experience Strategy & IA

Reframing clinical trial participation as a guided decision journey — UX strategy and IA from discovery through enrollment in a regulated research environment.

Clinical trial patient experience strategy

I led UX strategy and information architecture for the clinical trial participation platform. Working directly with clinical, regulatory, and digital teams, I owned the experience framework, journey design, decision support models, and content hierarchy from discovery through enrollment — translating regulatory constraints into a patient-facing experience structure that MLR could approve and product teams could execute from directly.
Lilly's clinical trials platform assumed patient awareness and education within a highly regulated research environment. The information architecture collapsed complex clinical realities into a linear promotional model that didn't reflect how patients actually navigate a trial decision. The experience gap wasn't informational — it was structural. Patients needed guided UX design, not a brochure.
I approached this as a structural experience design problem — defining a UX framework that mapped what patients needed to understand, feel, and do at each stage before asking them to act. I owned the IA, content hierarchy, and decision support design across the full platform — translating clinical and regulatory requirements into a patient experience architecture that progressive disclosure logic could hold together across every page.
Patient Journey Map & UX Site Architecture

Defined a phased UX delivery strategy for the Beacon platform — balancing launch urgency with long-term scalability. Phase 1 established core experience across five sections: What Are Clinical Trials, Benefits of Clinical Trials, Resources and Guides, Clinical Trial Search, and Clinical Trial FAQs — each designed as a standalone UX module at launch while serving as the foundation for Phase 2 expansion.

Patient Journey Map & UX Site Architecture
Information Architecture & Experience Design Framework

Translated the UX site architecture into a full information hierarchy model — mapping how clinical content is sequenced across all trial types to support progressive patient understanding from awareness through enrollment. Content was designed across three stages: awareness, consideration, and action — each requiring distinct UX patterns and content treatment.

Information Architecture & Experience Design Framework
MLR Submission Artifacts — Produced Site Pages

Three representative pages from the complete Beacon platform illustrating the UX content hierarchy and progressive disclosure design across three distinct stages of the patient decision journey. Trial search CTAs were designed and placed at moments of highest patient readiness. Clinical references and regulatory disclosures were integrated as structural UX elements — maintaining credibility without disrupting patient experience flow.

MLR Submission Artifacts
UX-led
Journey framework from discovery through enrollment
MLR-ready
Regulatory-compliant patient-facing experience architecture
3 stages
Progressive disclosure UX across awareness, consideration, action
UX AuditExperience DesignCRM ArchitecturePatient LifecycleMedical Device

Abbott FreeStyle Libre — UX Audit & Lifecycle Experience Design

Reducing early adoption risk by identifying UX friction and redesigning the full patient lifecycle experience — from first touch through confident device use.

Abbott FreeStyle Libre UX audit and experience design

I owned end-to-end UX strategy and experience design for the FreeStyle Libre patient lifecycle — from onboarding through long-term engagement. I defined the lifecycle experience framework, CRM communication architecture, behavioral sequencing model, and service blueprint that aligned clinical, regulatory, and digital delivery teams. AI-assisted research and competitive analysis informed UX benchmarks and regional experience patterns — while all design decisions remained grounded in Health Canada regulatory requirements for the Canadian market.
FreeStyle Libre was expanding CGM access into a mainstream healthcare audience — but the onboarding experience design was built for early adopters already motivated to engage. The UX sequencing didn't align with patient readiness — and drop-off during the critical first-use period was the measurable consequence. Patients received the right content at the wrong time, without a lifecycle experience model that understood where they were in the adoption journey.
I approached this as a lifecycle UX alignment problem — not a content or campaign problem. I designed a lifecycle experience framework that mapped what patients needed to understand, feel, and do at each stage. I mapped the behavioral and emotional arc across the full first-use period — from device activation through sustained engagement — and used that model to redesign the communication sequence, content prioritization, and channel timing across the onboarding experience.
Service Blueprint — UX Lifecycle Architecture

The FreeStyle Libre CRM Onboarding Service Blueprint defined the full patient lifecycle UX arc — establishing the phase structure, behavioral sequencing, and experience design logic that guided downstream CRM content, clinical messaging, and fulfillment operations across an 88-day engagement program. The blueprint organized the patient experience journey into ten distinct phases from device activation through program graduation.

Service Blueprint — UX Lifecycle Architecture
Lifecycle Communication Experience Design

The Lifecycle Communication Model translated the service blueprint into a complete experience design architecture spanning the full onboarding and engagement arc. Content was designed progressively: early communications established device confidence; mid-arc experiences introduced lifestyle integration and data interpretation; later-stage design shifted toward habit reinforcement and long-term self-management behaviors.

Lifecycle Communication Experience Design
MLR Submission Artifacts — Produced Email Experience Design

Final MLR-approved email experience design produced from the lifecycle communication system. Three emails represent distinct UX phases: 'Your journey starts today' oriented new patients; 'A continuous glucose monitor can help you achieve better outcomes' moved patients from device familiarity toward clinical understanding; 'You've worn your sensor for 13 straight days' shifted to behavioral reinforcement at a known UX drop-off risk point.

MLR Submission Artifacts — Email Experience Design
↓ 20%
User drop-off across the onboarding experience
88-day
Lifecycle UX engagement program designed
Health Canada
Fully compliant experience design across all assets
Experience DesignUX ArchitectureCompetitive IntelligenceOncologyBreast Cancer

Eli Lilly Verzenio — Experience Architecture & Competitive Intelligence

Designing oncology experience architecture to support informed treatment understanding across complex, multi-pathway disease management — backed by competitive landscape analysis.

Verzenio experience architecture and CI

I led experience design and UX architecture across the Verzenio patient support ecosystem — defining the structural design model that served both early and metastatic breast cancer patients without requiring separate platforms. I worked across clinical, regulatory, and brand teams to translate disease-stage complexity into a UX framework that held up under MLR review and gave product teams a single experience architecture to execute from.
Verzenio serves patients across meaningfully different disease stages — early breast cancer and metastatic — each with distinct treatment goals, support needs, and emotional contexts. A single undifferentiated UX model couldn't serve both without creating confusion or clinical risk. The experience design gap wasn't informational — it was architectural. Content existed but the UX structure didn't reflect where different patients actually were in their journey.
I approached this as a UX architecture and experience design problem — defining the structural model before any content or visual design decisions were made. Two UX sequencing models were designed: for EBC — Emotion→Evidence→Action; for MBC — Evidence→Context→Support. I mapped the full patient experience ecosystem across both disease stages, identifying where UX could share infrastructure and where experience design needed to diverge.
UX Alignment Framework — Early & Metastatic Breast Cancer Experience Design

The primary UX strategy tool used to align clinical messaging, experience design priorities, and sequencing logic across two distinct patient audiences within a single DTC web experience. The framework defined the core UX tension explicitly: one site, two opposing patient needs. Five UX design recommendations per audience across six content areas, with six MLR watch items sequenced for regulatory review alignment.

UX Alignment Framework
Mobile UX Structural Design Recommendations

UX structural and navigation design improvements across the Verzenio secondary pages for both EBC and MBC patient audiences. Core UX findings identified inconsistent sub-section labeling, hero visibility issues caused by cookie and safety banners, and isolated icon/block layouts that increased page length without improving experience scannability. MBC was identified as the source-of-truth UX navigation pattern.

Mobile UX Structural Design Recommendations
MLR Submission Artifacts — Produced Site Experience Design

Fully produced Verzenio DTC platform delivered following MLR review and approval across both EBC and MBC indications. Experience design followed the defined UX sequencing models — EBC: Emotion→Evidence→Action; MBC: Evidence→Context→Support — with distinct visual hierarchy and CTA design for each patient audience.

MLR Submission Artifacts
2
Patient experience journeys served from one UX architecture
MLR-approved
EBC and MBC DTC experience design delivered
6
MLR watch items sequenced into UX review alignment
Experience DesignGlobal UXCompetitive IntelligenceObesityScalable Platform

Eli Lilly Global Obesity — Digital Experience Design & Strategy

Designing a global UX framework that scales across markets — respecting cultural, regulatory, and health literacy differences while maintaining experience design consistency.

Global obesity experience design and strategy

I led global UX strategy and experience design — defining the information architecture, content hierarchy, and UX framework that coordinates across markets with different regulatory requirements, cultural contexts, and health literacy levels. I owned the global-to-local experience design logic and the dependency workflows between Lilly regional delivery teams. AI-assisted research and competitive analysis helped surface UX patterns and regional content gaps at a scale that manual synthesis alone couldn't match.
Lilly was advancing obesity initiatives across markets with substantively different regulatory environments, cultural perceptions of the disease, access models, and health literacy levels. A rigid global UX experience risked cultural missteps and local regulatory failure. Fully bespoke local experience design would create fragmentation and unsustainable maintenance overhead. Obesity care is deeply sensitive — patients navigate stigma, self-blame, complex treatment histories, and often years of failed interventions.
I approached this as a global UX architecture problem with local experience design sensitivity requirements — defining first where structural consistency was non-negotiable, and identifying where local design variation was required. I established the IA and UX principles that had to hold across all markets, and identified the specific flex zones where local teams needed full adaptive experience design control — regulatory language, cultural framing, access model logic, and disease perception context.
Global UX Information Architecture — Site Map Framework

The global UX site map defined the page hierarchy, content groupings, and experience design principles that had to remain consistent across all markets. The homepage anchored the experience with four stigma-reduction UX content modules before routing patients into four distinct experience pathways: Understanding Obesity, Weight Management Options, Weight Loss Journeys, and Talk to Your Doctor.

Global UX Information Architecture
Global Page UX Structure & Experience Design

Seven page-level mobile UX layouts validating content hierarchy, structural sequencing, and the global-to-local experience design logic across the most divergent market scenarios. The homepage established the emotional UX entry point — leading with stigma-reduction framing before introducing clinical content. The Quiz Module was a distinct UX type — a five-screen interactive questionnaire generating a personalized discussion guide, representing the highest-complexity local flex zone.

Global Page UX Structure & Experience Design
MLR Submission Artifacts — Produced Global Experience Design

Fully produced global obesity platform delivered following MLR review and approval. Homepage experience design opened with direct stigma-reduction framing — 'It's not our fault. We know now obesity is a disease' — before moving into the biological resistance UX flow. The Understanding Obesity page led with disease definition before introducing biological complexity through a carefully sequenced experience design hierarchy.

Produced Global Experience Design
Global
UX/IA framework designed across all markets
7
Page-level mobile UX layouts validated
MLR-approved
Global experience design delivered in regulated environments